X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   ADCOCK INGRAM
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
ADCOCK INGRAM
Jun-14
JUBILANT LIFE SCIENCES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs187367-   
Low Rs65265-   
Sales per share (Unadj.) Rs364.3109.1-  
Earnings per share (Unadj.) Rs6.8-27.5-  
Cash flow per share (Unadj.) Rs24.5-22.8-  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.985.7-  
Shares outstanding (eoy) m159.28168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 11.9%   
Avg P/E ratio x18.4-11.5 -160.2%  
P/CF ratio (eoy) x5.1-13.9 -37.1%  
Price / Book Value ratio x0.83.7 20.7%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,06153,291 37.6%   
No. of employees `0006.24.3 144.1%   
Total wages/salary Rs m11,0523,345 330.4%   
Avg. sales/employee Rs Th9,383.04,290.3 218.7%   
Avg. wages/employee Rs Th1,786.9779.1 229.3%   
Avg. net profit/employee Rs Th176.3-1,081.1 -16.3%   
INCOME DATA
Net Sales Rs m58,03418,418 315.1%  
Other income Rs m191129 147.8%   
Total revenues Rs m58,22418,547 313.9%   
Gross profit Rs m5,786-3,192 -181.3%  
Depreciation Rs m2,812795 353.7%   
Interest Rs m3,237499 648.8%   
Profit before tax Rs m-72-4,357 1.7%   
Minority Interest Rs m-286-12 2,355.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696272 255.8%   
Profit after tax Rs m1,090-4,641 -23.5%  
Gross profit margin %10.0-17.3 -57.5%  
Effective tax rate %-965.9-6.2 15,457.7%   
Net profit margin %1.9-25.2 -7.5%  
BALANCE SHEET DATA
Current assets Rs m29,28013,490 217.1%   
Current liabilities Rs m38,9127,590 512.7%   
Net working cap to sales %-16.632.0 -51.8%  
Current ratio x0.81.8 42.3%  
Inventory Days Days84111 76.1%  
Debtors Days Days51124 40.9%  
Net fixed assets Rs m55,7127,863 708.5%   
Share capital Rs m15586 180.7%   
"Free" reserves Rs m20,9680-   
Net worth Rs m26,26514,456 181.7%   
Long term debt Rs m17,1695,080 338.0%   
Total assets Rs m88,60627,309 324.5%  
Interest coverage x1.0-7.7 -12.6%   
Debt to equity ratio x0.70.4 186.0%  
Sales to assets ratio x0.70.7 97.1%   
Return on assets %4.9-15.2 -32.2%  
Return on equity %4.2-32.1 -12.9%  
Return on capital %11.6-19.8 -58.4%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Net fx Rs m10,2550-   
CASH FLOW
From Operations Rs m8,0261,572 510.5%  
From Investments Rs m-1,744-483 361.3%  
From Financial Activity Rs m-4,4474,611 -96.5%  
Net Cashflow Rs m1,8345,700 32.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.06 Rs / ZAR

Compare JUBILANT LIFE SCIENCES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare JUBILANT LIFE SCIENCES With: TTK HEALTHCARE  STRIDES PHARMA SCIENCE  ABBOTT INDIA  STERLING BIOTECH  WYETH LTD  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Nov 21, 2018 03:35 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS